Comparison of the effect of uric acid/albumin ratio on coronary slow flow with other inflammation-based markers
Background: Many inflammation-based markers (IBMs) have been shown to be closely related to coronary slow flow (CSF), but the effect of the uric acid/albumin ratio (UAR) on CSF and its relationship with other IBMs are not clearly known. In this study, we aimed to compare the effects of UAR and other IBMs on CSF. Methods: After the exclusion criteria, 126 patients with CSF detected on coronary angiography and 126 subjects with normal coronary flow as the control group were included in the study. Results: UAR was determined as an independent predictor for CSF. In addition, the UAR was superior to other IBMs in detecting CSF (p < 0.05 for all). Conclusion: This study is the first to investigate the effect of UAR on CSF in comparison with other IBMs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Biomarkers in medicine - 18(2024), 1 vom: 29. Jan., Seite 25-37 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Toprak, Kenan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
268B43MJ25 |
|---|
| Anmerkungen: |
Date Completed 29.02.2024 Date Revised 29.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/bmm-2023-0386 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368127494 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368127494 | ||
| 003 | DE-627 | ||
| 005 | 20240229234948.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240207s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/bmm-2023-0386 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM368127494 | ||
| 035 | |a (NLM)38323551 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Toprak, Kenan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of the effect of uric acid/albumin ratio on coronary slow flow with other inflammation-based markers |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.02.2024 | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background: Many inflammation-based markers (IBMs) have been shown to be closely related to coronary slow flow (CSF), but the effect of the uric acid/albumin ratio (UAR) on CSF and its relationship with other IBMs are not clearly known. In this study, we aimed to compare the effects of UAR and other IBMs on CSF. Methods: After the exclusion criteria, 126 patients with CSF detected on coronary angiography and 126 subjects with normal coronary flow as the control group were included in the study. Results: UAR was determined as an independent predictor for CSF. In addition, the UAR was superior to other IBMs in detecting CSF (p < 0.05 for all). Conclusion: This study is the first to investigate the effect of UAR on CSF in comparison with other IBMs | ||
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a coronary slow flow | |
| 650 | 4 | |a inflammation-based markers | |
| 650 | 4 | |a uric acid/albumin ratio | |
| 650 | 7 | |a Albumins |2 NLM | |
| 650 | 7 | |a Uric Acid |2 NLM | |
| 650 | 7 | |a 268B43MJ25 |2 NLM | |
| 700 | 1 | |a Özen, Kaya |e verfasserin |4 aut | |
| 700 | 1 | |a Memioğlu, Tolga |e verfasserin |4 aut | |
| 700 | 1 | |a İnanır, Mehmet |e verfasserin |4 aut | |
| 700 | 1 | |a Kaplangöray, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Akyol, Selahattin |e verfasserin |4 aut | |
| 700 | 1 | |a Tascanov, Mustafa B |e verfasserin |4 aut | |
| 700 | 1 | |a Biçer, Asuman |e verfasserin |4 aut | |
| 700 | 1 | |a Demirbağ, Recep |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomarkers in medicine |d 2007 |g 18(2024), 1 vom: 29. Jan., Seite 25-37 |w (DE-627)NLM184946271 |x 1752-0371 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2024 |g number:1 |g day:29 |g month:01 |g pages:25-37 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/bmm-2023-0386 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2024 |e 1 |b 29 |c 01 |h 25-37 | ||